Shahana Masood, MD
Sleep Medicine · Orange City, FLNPI 1275730244
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 269 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,027 and has fallen 72.9% since, to $549 in 2025.
Across 269 payments — averaging $23.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$784
- Mallinckrodt Hospital Products Inc.$510
- Grifols USA, LLC$442
- Boehringer Ingelheim$383
- Jazz Pharmaceuticals Inc.$340
- plus $3K from 33 others
What the payments were for
- Food & beverage$6,15397%
- Education$2133%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 44 | $1,194 |
| GSK | 57 | $784 |
| Mallinckrodt Hospital Products Inc. | 16 | $510 |
| Grifols USA, LLC | 17 | $442 |
| Boehringer Ingelheim | 17 | $383 |
| Jazz Pharmaceuticals Inc. | 7 | $340 |
| Inspire Medical Systems, Inc. | 3 | $250 |
| Sanofi | 5 | $220 |
| Pfizer | 12 | $217 |
| Genentech USA, Inc. | 11 | $187 |
| Pulmonx Corporation | 3 | $157 |
| Sunovion Pharmaceuticals Inc. | 12 | $151 |
| Mylan Specialty L.p. | 6 | $139 |
| Inari Medical, Inc. | 1 | $138 |
| Intuitive Surgical | 1 | $135 |
| Philips North America LLC | 6 | $121 |
| Electromed, Inc. | 9 | $114 |
| Johnson & Johnson | 1 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $94 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| ANI Pharmaceuticals, Inc. | 4 | $79 |
| Inogen, Inc. | 5 | $65 |
| Amgen | 2 | $56 |
| United Therapeutics Corporation | 2 | $47 |
| Insmed, Inc. | 3 | $42 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $33 |
| AbbVie | 2 | $33 |
| Melinta Therapeutics, LLC | 2 | $32 |
| Harmony Biosciences LLC | 1 | $27 |
| Novartis | 1 | $21 |
| Baxter Healthcare | 1 | $18 |
| Circassia Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Ceribell, Inc. | 1 | $13 |
| Boston Scientific | 1 | $12 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$244
- ACTHAR$229
- Prolastin-C Liquid$163
- XYWAV$142
- FLOWTRIEVER CATHETER, S$138
- CT THROMBECTOMY SYSTEM KIT$138
- TEZSPIRE$135
- ION$135
- FASENRA$130
- BREZTRI$124
- TAGRISSO$124
- Inspire Upper Airway Stimulation System$120
- CHARTIS CATHETER$116
- ZEPHYR DELIVERY CATHETER$116
- ZEPHYR ENDOBRONCHIAL VALVE$116
- PULMONX CHARTIS TABLET CONSOLE$116
- XARELTO$106
- OFEV$104
How this compares
$6,366 in reported general payments places this provider in the 75th percentile of 77 sleep medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 190 | $145,607 |
| Breo ElliptaFluticasone/Vilanterol | 80 | $32,821 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 45 | $24,066 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 31 | $19,453 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 38 | $18,303 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 12 | $5,821 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $5,809 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 60 | $5,404 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 55 | $1,424 |
| Montelukast Sodium | 70 | $510 |
| Azithromycin | 34 | $498 |
| Fluticasone Propionate | 34 | $476 |
| Bupropion Hcl SrBupropion Hcl | 13 | $403 |
| Ipratropium Bromide | 11 | $299 |
| Prednisone | 26 | $97 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $784 | $196,731308 claims |
| AstraZenecaBreztri Aerosphere, Bevespi Aerosphere, Symbicort | $1,194 | $31,08366 claims |
| Boehringer IngelheimStiolto Respimat | $383 | $24,06645 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 77 sleep medicine providers in Florida.
Other sleep medicine in Orange City
- Radhika VermaOrange City$14K
- Jeremy McConnellBradenton$615K
- Edward MezerhaneMiami$537K
- Shane DrahosWinter Garden$317K
- Kunal AgarwalSarasota$153K
- Camilo RuizFort Lauderdale$136K
- Sergio JaramilloMiami$32K
- Carlos Ramirez MejiaMiami$25K
- Luis OrtizSt Petersburg$24K
- Harneet WaliaMiami$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.